Regulation (EU) 2021/1281
Commission Implementing Regulation (EU) 2021/1281 of 2 August 2021 laying down rules for the application of Regulation (EU) 2019/6 of the European Parliament and of the Council as regards good pharmacovigilance practice and on the format, content and summary of the pharmacovigilance system master file for veterinary medicinal products (Text with EEA relevance)
In forceTyperegulationDate2 Aug 2021Since4 Jan 2022Articles28Versions held48Cited by6 documents
- 10Record management system
- 11Suspected adverse events
- 12Recording of adverse events
- 13Adverse event recording in the Union pharmacovigilance database
- 14Provision of additional data
- 15Post-marketing surveillance studies
- 16Risk management system
- 17Signal management process
- 18Monitoring benefit-risk balance
- 19Conclusion on the benefit-risk balance
- 20Communication
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).